| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 31, 2026 | Grant(A) | 250K | — | — | 250K |
| Mar 31, 2026 | Disposed to issuer(D) | 250K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 36K | — | — | 36K |
| Mar 31, 2026 | Disposed to issuer(D) | 36K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 12K | — | — | 12K |
| Mar 31, 2026 | Disposed to issuer(D) | 12K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 650K | — | — | 650K |
| Mar 31, 2026 | Disposed to issuer(D) | 650K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 125K | — | — | 125K |
| Mar 31, 2026 | Disposed to issuer(D) | 125K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 9K | — | — | 9K |
| Mar 31, 2026 | Disposed to issuer(D) | 9K | — | — | 0 |
| Mar 31, 2026 | Grant(A) | 22K | — | — | 22K |
| Mar 31, 2026 | Disposed to issuer(D) | 22K | — | — | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-023337) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Skye Bioscience, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.